February 13, 2025 Fourth Quarter and Full Year 2024 Results The revised project cost includes the original estimate of $700 million, plus scope changes of $120-$130 million, plus the impact of inflationary cost increases ranging from 25 to 35 percent. There have been no changes to the total project cost estimate range of $995 million to $1.075 billion. The estimated NPV, estimated IRR, estimated Payback calculation, projected valuation amounts, estimated production potential, anticipated schedule, estimated ...

Q4 2024 Earnings Presentation February 13, 2025 Forward-Looking Statements & Legal Disclaimers 2024.Q4 v9 P 3 WHO WE ARE Accelerated Recovery with Therapeutic Acute Wound Care OUR MISSION Our mission is to position AVITA Medical as a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. OUR IMPACT This presentation and the accompanying oral commentary are "forward-looki ...

4Q24 FINANCIAL RESULTS February 13, 2025 Global. Connected. Sustainable. The meeting place for companies, technologies and data Executing on Key Strategic Priorities Positioned for Long-Term Sustainable Growth 5,000+ Customers 227,000+ Cross Connects 50+ Metros 300+ Data Centers Capacity Host What You Need, How You Need Coverage Deploy Where You Need Connectivity Connect How You Need to Whom You Need Control Implement and Operate the Way You Need Strengthen Our Customer Value Proposition 1 2 3 Innovate & In ...

Earnings Presentation Fourth Quarter and Full Year 2024 Forward Looking Statements Some of the information contained herein are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used herein, words such as "believe," "expect," "anticipate," "estimate," "plan," "continue," "intend," "should," "may," "target," or similar expressions, are intended to identify such forward-looking statem ...

Fourth Quarter and Full Year Earnings Release Materials February 13, 2025 ARSEN KITCH President, Chief Executive Officer and Director SHERRI BAKER Senior Vice President and Chief Financial Officer Forward Looking Statements Cautionary Statement Regarding Forward Looking Statements This presentation of supplemental information contains, in addition to historical information, certain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of th ...

Q2 Fiscal Year 2025 Earnings Call February 13, 2025 © 2025 Palo Alto Networks, Inc. All rights reserved. Proprietary and confidential information. Safe Harbor This presentation contains "forward-looking" statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including the cybersecurity threat landscape, expectations regarding our platformization strategy and related progress and opportunities, long-term expectations regarding annual recurring revenue, remaini ...

Q SUITS CA February 13, 2025 :: Cellebrite Q4 & FY24 : Cellebrite DISCLAIMER पीढ़ presentation has deen prosesed in Calebication D Liber "Ocencery" jsobly for videormalinde loupposes. Nis not, and should not be easymeri o be porpolete. Nis presen पीढ़ presentable in noi dreeteb ig, or the cebooks for disclibrish to or use ly, any pessor or catility the la stiller or resident in only locally, sale, est of siddition angalation or white would resuire any redeletablin or ücesing with nouslings issussisted this ...

Financing the Growth of Tomorrow's Companies Today Q4 2024 INVESTOR PRESENTATION February 13, 2025 Important Notice: Forward Looking Statements This presentation may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You should understand that under Section 27A(b)(2)(B) of the Securities Act of 1933, as amended, and Section 21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the "safe harbor" provisions of the Pr ...

Dexcom Dexcom earnings Q4 2024 Digbetes Nasdag Safe harbor statement This presentation also contains non-GAAP financial measures. The appendix reconclies the non-GAAP financial measures in this presentation to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-G-AP financial mecsures include organic revenue, nor-GAAP gross profit, non-GAAP operating income (loss), non-GAAP operating income (loss), non-GAAP operating margin, ...

Q4 2024 investor conference call February 13, 2025 Caution regarding forward-looking statements Today's discussion may contain forward-looking statements, including statements relating to our objectives and our strategies to achieve those objectives, our 2025 targets, our expectations regarding trends in the telecommunications industry (including demand for data and ongoing subscriber base growth), and our financing plans (including our multi-year dividend growth program). Forward-looking statements are typ ...